METTL7A as a New Candidate Biomarker in Gastric Cancer by Genomics and Data-Independent Acquisition Proteomic Analysis.

IF 0.7 4区医学 Q4 MEDICAL LABORATORY TECHNOLOGY

Clinical laboratory Pub Date : 2025-03-01 DOI:10.7754/Clin.Lab.2024.240701

Xinying Li, Xiaojuan Gao, Xiqiu Yu, Zhiwei Zhou, Dan Xiong, Xiuming Zhang

{"title":"METTL7A as a New Candidate Biomarker in Gastric Cancer by Genomics and Data-Independent Acquisition Proteomic Analysis.","authors":"Xinying Li, Xiaojuan Gao, Xiqiu Yu, Zhiwei Zhou, Dan Xiong, Xiuming Zhang","doi":"10.7754/Clin.Lab.2024.240701","DOIUrl":null,"url":null,"abstract":"Background: Early diagnosis and intervention are essential for improving the prognosis and survival of gastric cancer (GC) patients. However, specific biomarkers for early GC diagnosis are still unavailable.Methods: Data-independent acquisition (DIA) proteomics was employed to identify differentially expressed proteins (DEPs) between GC and adjacent non-tumor tissues. Functional and pathway enrichment analyses were conducted, with subsequent genomic-level validation. Methyltransferase-like 7A (METTL7A) expression in GC versus adjacent tissues was confirmed via tissue microarray analysis. Correlations between METTL7A expression, clinical characteristics, and immune infiltration were also explored. Additionally, co-expressed genes related to METTL7A were analyzed, and gene set variation analysis (GSVA) was performed.Results: DIA proteomics identified 84 DEPs, mainly involved in protein binding and enriched in complement and coagulation pathways. Eight DEPs overlapped with results from the gene expression omnibus (GEO) dataset. METTL7A expression was significantly lower in GC tissues compared to adjacent tissues, confirmed at the genomic level. The cancer genome atlas (TCGA) analysis revealed an area under the receiver operating characteristic (ROC) curve (AUC) of 0.81, with METTL7A expression inversely correlated with age (p = 7.307e-05). Tissue microarray analysis further confirmed reduced METTL7A expression in GC tissues (p = 0.000). METTL7A expression was positively correlated with activated B cells and negatively correlated with activated CD4 T cells.Conclusions: METTL7A is a promising biomarker for early GC diagnosis.","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 3","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2024.240701","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Early diagnosis and intervention are essential for improving the prognosis and survival of gastric cancer (GC) patients. However, specific biomarkers for early GC diagnosis are still unavailable.

Methods: Data-independent acquisition (DIA) proteomics was employed to identify differentially expressed proteins (DEPs) between GC and adjacent non-tumor tissues. Functional and pathway enrichment analyses were conducted, with subsequent genomic-level validation. Methyltransferase-like 7A (METTL7A) expression in GC versus adjacent tissues was confirmed via tissue microarray analysis. Correlations between METTL7A expression, clinical characteristics, and immune infiltration were also explored. Additionally, co-expressed genes related to METTL7A were analyzed, and gene set variation analysis (GSVA) was performed.

Results: DIA proteomics identified 84 DEPs, mainly involved in protein binding and enriched in complement and coagulation pathways. Eight DEPs overlapped with results from the gene expression omnibus (GEO) dataset. METTL7A expression was significantly lower in GC tissues compared to adjacent tissues, confirmed at the genomic level. The cancer genome atlas (TCGA) analysis revealed an area under the receiver operating characteristic (ROC) curve (AUC) of 0.81, with METTL7A expression inversely correlated with age (p = 7.307e-05). Tissue microarray analysis further confirmed reduced METTL7A expression in GC tissues (p = 0.000). METTL7A expression was positively correlated with activated B cells and negatively correlated with activated CD4 T cells.

Conclusions: METTL7A is a promising biomarker for early GC diagnosis.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical laboratory 医学-医学实验技术

CiteScore

1.50

自引率

0.00%

发文量

494

审稿时长

3 months

期刊介绍： Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.